Quick Dispatch:
Your surmount 1 tirzepatide SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your surmount 1 tirzepatide SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes ships.
Need Help?
Questions about surmount 1 tirzepatide SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surmount 1 tirzepatide SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes in your area.
In the SURMOUNT-4 trial, 82.5% of adults with obesity regained ≥25% of initial weight lost within one year of tirzepatide withdrawal; most showed reversal of cardiometabolic improvements. https://bit.ly/4rBMZgh
22.56
SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients
23.51
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
24.67
SURMOUNT-1
28.74
01200-X/asset/a888810c-3ccf-4f48-b252-0dfdf720d276/main.assets/gr3_lrg.jpg)
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
24.03
Weight reduction with different doses of Tirzepatide in Surmount 1
25.69
Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program - Roux - 2023 - Obesity
28.60
